X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
60
PharmaCompass offers a list of Letrozole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Letrozole manufacturer or Letrozole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Letrozole manufacturer or Letrozole supplier.
PharmaCompass also assists you with knowing the Letrozole API Price utilized in the formulation of products. Letrozole API Price is not always fixed or binding as the Letrozole Price is obtained through a variety of data sources. The Letrozole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile, including repackagers and relabelers. The FDA regulates 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile supplier is an individual or a company that provides 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile active pharmaceutical ingredient (API) or 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile finished formulations upon request. The 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers may include 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile API manufacturers, exporters, distributors and traders.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile DMF (Drug Master File) is a document detailing the whole manufacturing process of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile active pharmaceutical ingredient (API) in detail. Different forms of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile DMFs exist exist since differing nations have different regulations, such as 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile DMF submitted to regulatory agencies in the US is known as a USDMF. 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile USDMF includes data on 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile Drug Master File in Japan (4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile JDMF) empowers 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile JDMF during the approval evaluation for pharmaceutical products. At the time of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile Drug Master File in Korea (4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile. The MFDS reviews the 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile KDMF as part of the drug registration process and uses the information provided in the 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile KDMF to evaluate the safety and efficacy of the drug.
After submitting a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with KDMF on PharmaCompass.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP of the European Pharmacopoeia monograph is often referred to as a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile Certificate of Suitability (COS). The purpose of a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile to their clients by showing that a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP has been issued for it. The manufacturer submits a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP (COS) as part of the market authorization procedure, and it takes on the role of a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP holder for the record. Additionally, the data presented in the 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile DMF.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with CEP (COS) on PharmaCompass.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile written confirmation (4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile WC) is an official document issued by a regulatory agency to a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile manufacturer, verifying that the manufacturing facility of a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile APIs or 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile finished pharmaceutical products to another nation, regulatory agencies frequently require a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile WC (written confirmation) as part of the regulatory process.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile suppliers with NDC on PharmaCompass.
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile GMP manufacturer or 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile GMP API supplier for your needs.
A 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CoA (Certificate of Analysis) is a formal document that attests to 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile's compliance with 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile specifications and serves as a tool for batch-level quality control.
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CoA mostly includes findings from lab analyses of a specific batch. For each 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile may be tested according to a variety of international standards, such as European Pharmacopoeia (4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile EP), 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile JP (Japanese Pharmacopeia) and the US Pharmacopoeia (4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile USP).
Market Place
